Rosette M. Roat-Malone - Bioinorganic Chemistry

..Figure 4.3 [Fe]‐hydrogenase active site from the X‐ray crystallographic entr...Figure 4.4 PDB 4U9H [NiFe]‐hydrogenase active site.Figure 4.5 Catalytic cycle for [NiFe]‐hydrogenase.Figure 4.6 PDB 4UD6 Ni‐C form in the [NiFe]‐hydrogenase catalytic cycle illu...Figure 4.7 [NiFe]‐hydrogenase model compound.Figure 4.8 [NiFe]‐hydrogenase model compounds. (a) dppe = 1,2‐bis(diphenylph...Figure 4.9 Model compounds representing [NiFe]‐hydrogenase Ni‐L state (react...Figure 4.10 [NiFe]‐hydrogenase model compound illustrating H 2cleavage at th...Figure 4.11 Possible proton pathways to the H‐cluster involving amino‐acid r...Figure 4.12 Amino‐acid network surrounding the 2Fe Hsubcluster for the CpI AD...Figure 4.13 [FeFe]‐hydrogenase model complexes that produce H 2.Figure 4.14 Proposed [Fe]‐hydrogenase catalytic cycle.Figure 4.15 [Fe]‐hydrogenase model compounds: (a) short‐lived model compound...Figure 4.16 Human carbonic anhydrase II (hCAII), PDB 1CA2.Figure 4.17 Hydrophilic water channel leading to the Zn 2+active site and hy...Figure 4.18 Methazolamide interaction at the hCA II active site PDB 5C8I [34...Figure 4.19 Trifluoro hydroxamate hCA II inhibitor at the active site PDB 1A...Figure 4.20 The nitrogen cycle.Figure 4.21 iNOS active site with substrate L‐arginine from PDB 1NOD [48].Figure 4.22 PDB 1M8D iNOS oxwith inhibitor chlorzoxazone from reference [44]...Figure 4.23 Inducible NOS inhibitors from reference [49].Figure 4.24 L‐arginine and amidine inactivators of iNOS from reference [45]....Figure 4.25 PDB 5VV5 active site of hnNOS with inhibitor bound [51].Figure 4.26 Siroheme‐[4Fe4S] cluster active site for CSNIR nitrite reductase...Figure 4.27 Hemes and types I and II copper centers found in various NO enzy...Figure 4.28 Cd 1NIR nitrite reductase visualized from PDB 1NIR [54].Figure 4.29 Type I and type II copper sites for the nitrite reductase enzyme...Figure 4.30 Copper complex catalyzing the reaction forming NO from nitrite i...Figure 4.31 Route 2 mechanism for NO(g) release in CuNIR nitrite reductase [...Figure 4.32 CuNIR model complexes studied in reference [60].Figure 4.33 Model complexes and reactions with NO(g) [64].

5 Chapter 5Figure 5.1 Reconfigurable DNA tripods (a) tripod design: each arm consists o...Figure 5.2 (a) An ssDNA scaffold hybridizes with staple and capture strands ...Figure 5.3 Three major motifs for building two‐ and three‐dimensional DNA na...Figure 5.4 Scaffold (long ssDNA) and staple (short ssDNA) used to create nan...Figure 5.5 (a) Biotin and (b) streptavidin as connectors for nucleic acids t...Figure 5.6 Response of a gold nanorod‐DNA origami template nanostructure to ...Figure 5.7 Sizes and shapes of some important nanomaterials and other matter...Figure 5.8 Formation of a hybrid nanogel system.Figure 5.9 (a) Sizes, shapes, and surface‐functionalized nanoparticles targe...Figure 5.10 Functionalizing ligands for inorganic nanoparticles.Figure 5.11 Anticancer agents delivered in single‐ and multi‐wall carbon nan...

6 Chapter 6Figure 6.1 Structures of platinum anticancer agents approved for clinical us...Figure 6.2 Platinum(II) compounds approved for use outside the United States...Figure 6.3 An antitumor active trans ‐platinum(II) compounds BBR3464 (Triplat...Figure 6.4 Dickerson Dodecamer (DDD) in complex with Triplatin indicating ph...Figure 6.5 Disaccharide linkages in heparan sulfate (HS).Figure 6.6 (a) Phosphate clamp; (b) sulfate clamp; (c) phosphate–arginine fo...Figure 6.7 Antitumor drugs used in combination with platinum‐containing anti...Figure 6.8 The anticancer platinum(IV) prodrug mitaplatin.Figure 6.9 (a) Formation of the metal‐organic cage (MOC) (b) formation of th...Figure 6.10 Ruthenium(III) antitumor compounds NAMI‐A, KP1019, and NKP1339....Figure 6.11 X‐ray crystallographic structure of NAMI‐A reaction products wit...Figure 6.12 Ruthenium(II) half sandwich antitumor compounds RAED‐C and RAPTA...Figure 6.13 [RuCl 2(η 6‐arene)(η 1‐S‐aroylthiourea)] anticancer active complexe...Figure 6.14 Cartoon representation of [RuCl 2(η 6‐arene)(η 1‐S‐aroylthiourea)] ...Figure 6.15 Comparison of activity of Ir and Ru half‐sandwich complexes.Figure 6.16 (a) Ruthenium(II) and (b) Iridium(II) antitumor complexes.Figure 6.17 Ruthenium(II) and osmium(II) antitumor complexes.Figure 6.18 Osmium(II) antitumor complexesFigure 6.19 Gold and titanium antitumor compounds.Figure 6.20 Copper complexes in clinical trials.Figure 6.21 Bismuth drugs and drug components.Figure 6.22 Colloidal bismuth subcitrate (CBS).Figure 6.23 (a) Structure Cu‐only SodC from Mycobacterium tuberculosis , (b) ...Figure 6.24 Superoxide dismutase variants found in prokaryotic bacteria and ...Figure 6.25 MnSOD2 in Homo sapiens susceptible to nitration inactivation and...Figure 6.26 Drugs used in ALS treatment.Figure 6.27 X‐ray structures of ALS mutants. (a) Metal‐reconstituted CuZn SO...Figure 6.28 Riluzole and active riluzole‐triazole hybrid compounds.Figure 6.29 Drugs or potential drugs used in Menkes disease treatment.Figure 6.30 Drugs or potential drugs used in Wilson disease treatment.Figure 6.31 (a) Aβ 1–42peptide dimer determined by cryo‐electron micro...Figure 6.32 Metal coordination spheres for (a) Cu(I)–Aβ peptide; (b) Cu(II)–...Figure 6.33 (a) copper chelator PBT2; (b) copper chelator gtsm; (c) copper c...Figure 6.34 Drugs used combination therapy with arsenic trioxide for treatme...Figure 6.35 (a–d) Vanadium compounds used in type 2 diabetes treatment; (e, ...

1 Cover

2 Table of Contents

3 Begin Reading

1 iii

2 iv

3 v

4 xiii

5 xiv

6 xv

7 xvii

8 xix

9 xxi

10 xxii

11 1

12 2

13 3

14 4

15 5

16 6

17 7

18 8

19 9

20 10

21 11

22 12

23 13

24 14

25 15

26 16

27 17

28 18

29 19

30 20

31 21

32 22

33 23

34 24

35 25

36 26

37 27

38 28

39 29

40 30

41 31

42 32

43 33

44 34

45 35

46 36

47 37

48 38

49 39

50 40

51 41

52 42

53 43

54 44

55 45

56 46

57 47

58 48

59 49

60 50

61 51

62 52

63 53

64 54

65 55

66 56

67 57

68 58

69 59

70 60

71 61

72 63

73 64

74 65

75 66

76 67

77 68

78 69

79 70

80 71

81 72

82 73

83 74

84 75

85 76

86 77

87 78

88 79

89 80

90 81

91 82

92 83

93 84

94 85

95 86

96 87

97 88

98 89

99 90

100 91

101 92

102 93

103 94

104 95

105 96

106 97

107 98

108 99

109 100

110 101

111 102

112 103

113 104

114 105

115 106

116 107

117 108

118 109

119 110

120 111

121 112

122 113

123 114

124 115

125 116

126 117

127 118

128 119

129 120

130 121

131 122

132 123

133 124

134 125

135 126

136 127

137 128

138 129

139 130

140 131

141 132

142 133

143 134

144 135

145 136

146 137

147 138

148 139

149 140

150 141

151 142

152 143

153 144

154 145

155 146

156 147

157 148

158 149

159 150

160 151

161 152

162 153

163 154

164 155

165 156

166 157

167 158

168 159

169 160

170 161

171 162

172 163

173 165

174 166

175 167

176 168

Читать дальше